Vimarsana
Biggest News Aggregation in the World

Page 14 - Adenosine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adenosine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adenosine Today - Breaking & Trending Today

Novel peptide helps prevent seizures, protects neurons in research models of both Alzheimer's and epilepsy - Vimarsana News

Novel peptide helps prevent seizures, protects neurons in research models of both Alzheimer's and epilepsy

A novel peptide augments the brain's natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer's and epilepsy, scientists report.

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction - Vimarsana News

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

In newly released research, scientists assessed the cardiac effects of remdesivir.

USPTO Patent Trial On Claim Construction Suit - Vimarsana News

USPTO Patent Trial On Claim Construction Suit

The Federal Circuit noted, the relevant claim language, especially when viewed in the context of the whole claim, is not plain on its face, but rather contains evident uncertainties that weighed against U. Mass’s construction, decision might leave an open door to challenge

Novel nanoparticle therapeutics shows promise to fight solid tumors - Vimarsana News

Novel nanoparticle therapeutics shows promise to fight solid tumors

Researchers from Wake Forest University School of Medicine have discovered a possible new approach to treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer.

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors - Vimarsana News

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.